INR 301.35
(2.64%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.91 Billion INR | -35.79% |
2022 | 1.8 Billion INR | 5.76% |
2021 | 1.7 Billion INR | -4.15% |
2020 | 1.77 Billion INR | 21.99% |
2019 | 1.45 Billion INR | 15.18% |
2018 | 1.26 Billion INR | -15.63% |
2017 | 1.49 Billion INR | 0.48% |
2016 | 1.49 Billion INR | 16.02% |
2015 | 1.28 Billion INR | -10.1% |
2014 | 1.42 Billion INR | 7.2% |
2013 | 1.33 Billion INR | 19.55% |
2012 | 1.11 Billion INR | 12.93% |
2011 | 988.06 Million INR | 9.67% |
2010 | 900.95 Million INR | 46.2% |
2009 | 616.24 Million INR | 41.78% |
2008 | 434.65 Million INR | 34.8% |
2007 | 322.44 Million INR | 58.48% |
2006 | 203.46 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 215.1 Million INR | -40.15% |
2024 Q2 | 332.4 Million INR | 54.53% |
2023 FY | 1.15 Billion INR | -35.79% |
2023 Q1 | 443.6 Million INR | 23.76% |
2023 Q3 | 248.4 Million INR | -57.79% |
2023 Q4 | 359.4 Million INR | 44.69% |
2023 Q2 | 588.5 Million INR | 32.66% |
2022 Q1 | 502 Million INR | 39.64% |
2022 Q4 | 358.45 Million INR | -21.55% |
2022 FY | 1.8 Billion INR | 5.76% |
2022 Q3 | 456.9 Million INR | -5.56% |
2022 Q2 | 483.8 Million INR | -3.63% |
2021 Q2 | 478.6 Million INR | 13.3% |
2021 Q4 | 359.5 Million INR | -21.45% |
2021 Q1 | 422.4 Million INR | 40.62% |
2021 FY | 1.7 Billion INR | -4.15% |
2021 Q3 | 457.7 Million INR | -4.37% |
2020 Q3 | 437.01 Million INR | -7.86% |
2020 Q2 | 474.3 Million INR | -16.05% |
2020 Q4 | 300.37 Million INR | -31.27% |
2020 Q1 | 564.95 Million INR | 74.83% |
2020 FY | 1.77 Billion INR | 21.99% |
2019 Q3 | 394.33 Million INR | 7.6% |
2019 Q2 | 366.48 Million INR | 6.1% |
2019 Q4 | 323.15 Million INR | -18.05% |
2019 Q1 | 345.4 Million INR | 34.49% |
2019 FY | 1.45 Billion INR | 15.18% |
2018 Q1 | 310.08 Million INR | 0.0% |
2018 FY | 1.26 Billion INR | -15.63% |
2018 Q4 | 256.82 Million INR | -29.03% |
2018 Q3 | 361.87 Million INR | 7.82% |
2018 Q2 | 335.62 Million INR | 8.24% |
2017 FY | 1.49 Billion INR | 0.48% |
2016 FY | 1.49 Billion INR | 16.02% |
2016 Q4 | 287.53 Million INR | 0.0% |
2015 FY | 1.28 Billion INR | -10.1% |
2014 FY | 1.42 Billion INR | 7.2% |
2013 Q1 | 296.03 Million INR | -3.84% |
2013 Q3 | 356.14 Million INR | 0.0% |
2013 Q4 | 378.89 Million INR | 6.39% |
2013 FY | 1.33 Billion INR | 19.55% |
2012 Q1 | 276.95 Million INR | 0.0% |
2012 FY | 1.11 Billion INR | 12.93% |
2012 Q2 | 273.02 Million INR | -1.42% |
2012 Q3 | 257.96 Million INR | -5.52% |
2012 Q4 | 307.84 Million INR | 19.34% |
2011 FY | 988.06 Million INR | 9.67% |
2010 FY | 900.95 Million INR | 46.2% |
2009 FY | 616.24 Million INR | 41.78% |
2008 FY | 434.65 Million INR | 34.8% |
2007 FY | 322.44 Million INR | 58.48% |
2006 FY | 203.46 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 87.925% |
Aurobindo Pharma Limited | 39.23 Billion INR | 95.116% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 83.538% |
Granules India Limited | 7.18 Billion INR | 73.32% |
Indoco Remedies Limited | 4.74 Billion INR | 59.647% |
Achyut Healthcare Limited | 1.6 Million INR | -118997.825% |
Ajanta Pharma Limited | 30.46 Billion INR | 93.709% |
Alkem Laboratories Limited | 32.83 Billion INR | 94.164% |
Alpa Laboratories Limited | 156.14 Million INR | -1127.231% |
Brooks Laboratories Limited | 51.18 Million INR | -3644.205% |
AstraZeneca Pharma India Limited | 2.6 Billion INR | 26.308% |
Bajaj HealthCare Limited | 985.34 Million INR | -94.478% |
Bliss GVS Pharma Limited | 1.41 Billion INR | -35.024% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 98.001% |
Eris Lifesciences Limited | 4.94 Billion INR | 61.232% |
FDC Limited | 5.34 Billion INR | 64.172% |
Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 97.164% |
Gufic Biosciences Limited | 1.07 Billion INR | -77.811% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 9.787% |
Ipca Laboratories Limited | 13.91 Billion INR | 86.229% |
Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -147.771% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -4051.755% |
Lasa Supergenerics Limited | 291.17 Million INR | -558.123% |
Laurus Labs Limited | 3.01 Billion INR | 36.353% |
Lupin Limited | 95.67 Billion INR | 97.997% |
Mankind Pharma Limited | 23.15 Billion INR | 91.723% |
Medicamen Biotech Limited | 335.16 Million INR | -471.74% |
Medico Remedies Limited | 161.84 Million INR | -1084.032% |
Megasoft Limited | 49.52 Million INR | -3769.092% |
NATCO Pharma Limited | 10.05 Billion INR | 80.948% |
Piramal Pharma Limited | 19.91 Billion INR | 90.377% |
RPG Life Sciences Limited | 1.63 Billion INR | -17.168% |
Sigachi Industries Limited | 579.88 Million INR | -230.458% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 98.757% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | -36.605% |
Syncom Formulations (India) Limited | 942.39 Million INR | -103.341% |
Unichem Laboratories Limited | 6.72 Billion INR | 71.509% |
Wanbury Limited | 1.16 Billion INR | -65.065% |
Windlas Biotech Limited | 1 Billion INR | -90.389% |
ZIM Laboratories Limited | 1.01 Billion INR | -89.158% |
Zydus Lifesciences Limited | 43.17 Billion INR | 95.561% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 37.718% |
Divi's Laboratories Limited | 14.17 Billion INR | 86.476% |
Hester Biosciences Limited | 908.84 Million INR | -110.849% |
Procter & Gamble Health Limited | 2.99 Billion INR | 36.026% |
Amrutanjan Health Care Limited | 1.09 Billion INR | -74.368% |
Bal Pharma Limited | 389.89 Million INR | -391.493% |
Strides Pharma Science Limited | 9.16 Billion INR | 79.085% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 37.67% |
Nectar Lifesciences Limited | 625.55 Million INR | -206.336% |
Shilpa Medicare Limited | 2.18 Billion INR | 12.121% |
Aarti Drugs Limited | 1.16 Billion INR | -64.139% |
IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -74.398% |
Suven Life Sciences Limited | 109.75 Million INR | -1646.045% |
Ind-Swift Limited | 946.56 Million INR | -102.446% |
Valiant Laboratories Limited | 36.28 Million INR | -5180.619% |
J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 77.233% |
Solara Active Pharma Sciences Limited | 4.57 Billion INR | 58.157% |
Themis Medicare Limited | 782.85 Million INR | -144.781% |
Hikal Limited | 2.48 Billion INR | 22.928% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 91.055% |
Sequent Scientific Limited | 2.9 Billion INR | 33.962% |
Novartis India Limited | 470.1 Million INR | -307.633% |
Wockhardt Limited | 6.4 Billion INR | 70.058% |
Jubilant Pharmova Limited | 14.45 Billion INR | 86.742% |
Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -11721.836% |
Neuland Laboratories Limited | 2.92 Billion INR | 34.592% |
Morepen Laboratories Limited | 1.98 Billion INR | 3.581% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -364.636% |
Mangalam Drugs & Organics Limited | 676.14 Million INR | -183.412% |